Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

After China Trade Deal, Trump Takes Aim at Europe

The Trump administration has taken a tough stance in international trade negotiations. With the US-China deal sealed and Congress set to vote on the US-Mexico-Canada accord, will the European Union be President Trump’s next target? Kenny Fisher ...
FX Empire | December 18, 2019 |

Is Trump Reversing Course On Iran?

The Trump administration is attempting to dial down the tension with Iran, lowering the risk of military conflict and pushing for diplomatic negotiations. On Sunday, U.S. Secretary of State Mike Pompeo said that the U.S. was ready to negotiate with Iran with "no precondi...
Nick Cunningham | June 4, 2019 |

Gilead, Teva, XPhyto - Global marketing potential

The best business models solve problems and are scalable. In this context, the healthcare sector is particularly interesting. The world's population has recently reached 7.8 billion people and for this reason solutions can meet a large potential market with users. Cross-border...
Mario Hose | June 16, 2020 |

Financial Crisis 2008: Is the Story Going to Repeat?

The coming year has the potential for a combination of major risks to the global economy coming together to cause a financial crisis rivaling that of 2008-09. The mortgage bubble that burst in 2008 led to multiple failures of financial institutions, major downturns in global...
Carl Cotton | March 15, 2019 |

CVS Declares Quarterly Dividend and Gets a Boost from Relaxed Rebate Policy

CVS Healthcare announced a $0.50/share quarterly dividend yesterday and got an added boost today as news spreads regarding easing of federal restrictions on pharmacy rebate plans. CVS Health Corp. (CVS:NYSE) along with many other pharmacy benefits manag...
Streetwise Reports | July 12, 2019 |

2021: A Breakout Year for Uranium Investments?

(Image via Anfield Energy Inc.) The Athabasca Basin is perhaps best known as the world’s leading source of high-grade uranium and currently supplies about 20% of the world’s uranium. It is a region in the Canadian Shield that enco...
Stockhouse Editorial | February 26, 2021 |

Three safe-haven reasons to own gold

“It’s the tail that wags the dog” is defined by Urban Dictionary as a way of persuading a large group of people. The phrase is usually employed in a situation wherein a cause that expects to elicit a certain effect, is in fact reversed. ...
Richard (Rick) Mills | May 21, 2019 |

U.S. Treasury Removes China as Currency Manipulator

The U.S. has formally removed China as a currency manipulator, just ahead of the signing of the ‘Phase 1’ deal. Given its past record, will China really change its ways? Kenny Fisher There was another positive develop...
FX Empire | January 14, 2020 |

The end of the global economy

The Trump administration has just granted its Commerce Department sweeping powers to slap tariffs on countries it decides are manipulating their currencies to the detriment of the United States and its exporting companies. For some this will come as news; at AOTH, it is c...
Richard (Rick) Mills | February 7, 2020 |

Allakos Shares Double on AK002 Phase 2 Results and Earnings

Allakos Inc. shares are soaring today as the company reported Q2/19 earnings and announced positive results from its phase 2 study for its AK002 inhibitor used in the treatment of eosinophil and mast cell related diseases. Clinical stage biotech company Allak...
Streetwise Reports | August 7, 2019 |
1 2 3 4 5 6 7 8 9 10 ...